Clinical Trial Update: Extracorporeal Support for Respiratory Insufficiency (ECMO) [Phase 3]

View source ↗

Summary

Phase 3 trial of extracorporeal membrane oxygenation (ECMO) for respiratory insufficiency has completed; study update from NHLBI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Diseases
• Respiratory Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Acute Respiratory Failure, Lung Diseases | Phase 3 | Status: COMPLETED